1. Home
  2. LGL vs DYAI Comparison

LGL vs DYAI Comparison

Compare LGL & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGL
  • DYAI
  • Stock Information
  • Founded
  • LGL 1917
  • DYAI 1979
  • Country
  • LGL United States
  • DYAI United States
  • Employees
  • LGL N/A
  • DYAI N/A
  • Industry
  • LGL Industrial Machinery/Components
  • DYAI Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LGL Technology
  • DYAI Health Care
  • Exchange
  • LGL Nasdaq
  • DYAI Nasdaq
  • Market Cap
  • LGL 35.6M
  • DYAI 29.6M
  • IPO Year
  • LGL N/A
  • DYAI 2004
  • Fundamental
  • Price
  • LGL $7.30
  • DYAI $0.97
  • Analyst Decision
  • LGL
  • DYAI Strong Buy
  • Analyst Count
  • LGL 0
  • DYAI 1
  • Target Price
  • LGL N/A
  • DYAI $6.00
  • AVG Volume (30 Days)
  • LGL 40.5K
  • DYAI 41.0K
  • Earning Date
  • LGL 08-12-2025
  • DYAI 08-12-2025
  • Dividend Yield
  • LGL N/A
  • DYAI N/A
  • EPS Growth
  • LGL 204.51
  • DYAI N/A
  • EPS
  • LGL 0.08
  • DYAI N/A
  • Revenue
  • LGL $4,322,000.00
  • DYAI $3,554,344.00
  • Revenue This Year
  • LGL N/A
  • DYAI $22.56
  • Revenue Next Year
  • LGL N/A
  • DYAI $30.95
  • P/E Ratio
  • LGL $100.72
  • DYAI N/A
  • Revenue Growth
  • LGL 20.66
  • DYAI 57.59
  • 52 Week Low
  • LGL $5.03
  • DYAI $0.91
  • 52 Week High
  • LGL $9.74
  • DYAI $2.20
  • Technical
  • Relative Strength Index (RSI)
  • LGL 67.76
  • DYAI 48.57
  • Support Level
  • LGL $6.73
  • DYAI $0.95
  • Resistance Level
  • LGL $9.74
  • DYAI $1.06
  • Average True Range (ATR)
  • LGL 0.96
  • DYAI 0.05
  • MACD
  • LGL 0.09
  • DYAI 0.01
  • Stochastic Oscillator
  • LGL 45.08
  • DYAI 53.33

About LGL LGL Group Inc. (The)

LGL Group Inc is a holding company engaged in services, merchant investment and manufacturing business activities. The company has two reportable segments; Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.

About DYAI Dyadic International Inc.

Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

Share on Social Networks: